The FDA is scheduled to conduct a public meeting in Maryland on Sept. 16 to discuss an Institute of Medicine report recommending the replacement of the agency's 510(k) clearance process for medical devices. The agency also set a Sept. 30 deadline for public comments on the IOM's recommendations.

Related Summaries